Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 6Fibrosis 3Lymphedema 2Head and Neck Neoplasms 2Sarcoidosis, Pulmonary 1Primary Ovarian Insufficiency 1Polycystic Ovary Syndrome 1Pain 1Non-small Cell Lung Cancers 1Mucositis 1Long-term Adverse Effects of Radiotherapy for Pelvic Cancer 1Erectile Dysfunction 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Cancer Female 1Brain Neoplasms 1

Interventions

Tamoxifen 2Paclitaxel 2pyrotinib 1pembrolizumab 1palbociclib 1iniparib 1darolutamide 1Thioctic Acid 1Pentoxifylline 1Metformin 1Letrozole 1Doxorubicin 1Cyclophosphamide 1Capecitabine 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Breast Cancer Female × Pentoxifylline × Clear all
NCT06176339 2024-03-15

Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"

Mansoura University

Phase 2 Unknown
70 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡